AGY stock news
This page provides real-time market news, earnings updates, and company announcements related to Allergy Therapeutics plc (AGY).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-14 06:31 GMT
Aquestive Therapeutics to Present New Clinical Data on Anaphylm (dibutepinephrine) Sublingual Film at the 2026 AAAAI Annual Meeting
Finviz2026-02-20 12:03:40
Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-23 12:03:47
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab's First-in-Class and Best-in-Disease Profile
Finviz2026-02-23 13:04:05
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
Finviz2026-02-23 13:03:50
Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay
Finviz2026-02-23 21:36:38
Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition
Finviz2026-02-23 21:45:36
Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
Finviz2026-02-24 12:03:58
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ
Finviz2026-02-27 13:36:43
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Is Regeneron Pharmaceuticals Shares Lagging Behind the Nasdaq?
101 finance2026-02-28 08:24:15
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
Finviz2026-02-28 14:48:40
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Finviz2026-03-01 14:48:40
Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026
Finviz2026-03-02 11:54:11
OGN's VTAMA Cream Shows Sleep Benefits in Pediatric Atopic Dermatitis
Finviz2026-03-02 19:03:10
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Finviz2026-03-03 12:33:14
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-04 21:24:44
DBV Technologies to Participate in Upcoming March Investor Conferences
Finviz2026-03-04 21:33:44
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy (epinephrine nasal spray) Commercialization
Finviz2026-03-09 10:03:43
ARS Pharmaceuticals Inc (NASDAQ: SPRY) announces that the regulatory approval timeline for its nasal spray epinephrine product Neffy in Canada has been clarified.
老虎证券2026-03-09 10:12:22
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-09 20:06:47
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-12 20:06:49
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-12 20:06:49
Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay
Finviz2026-02-23 21:36:38
Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition
Finviz2026-02-23 21:45:36
Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
Finviz2026-02-24 12:03:58
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ
Finviz2026-02-27 13:36:43
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Is Regeneron Pharmaceuticals Shares Lagging Behind the Nasdaq?
101 finance2026-02-28 08:24:15
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
Finviz2026-02-28 14:48:40
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Finviz2026-03-01 14:48:40
Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026
Finviz2026-03-02 11:54:11
OGN's VTAMA Cream Shows Sleep Benefits in Pediatric Atopic Dermatitis
Finviz2026-03-02 19:03:10
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Finviz2026-03-03 12:33:14
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-04 21:24:44
DBV Technologies to Participate in Upcoming March Investor Conferences
Finviz2026-03-04 21:33:44
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy (epinephrine nasal spray) Commercialization
Finviz2026-03-09 10:03:43
ARS Pharmaceuticals Inc (NASDAQ: SPRY) announces that the regulatory approval timeline for its nasal spray epinephrine product Neffy in Canada has been clarified.
老虎证券2026-03-09 10:12:22
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-09 20:06:47
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-12 20:06:49
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-12 20:06:49
AGY stock price change
On the last trading day, AGY stock closed at 11.50 GBP, with a price change of 0.00% for the day.
Trade stock perpsAGY stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more